Publication: 3894

Publication: 3894

Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Pharmacogenomics J vol 24 (2)

Year:: 2024
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: 2145 2448
Children:: None

Program:: OGC
Primary Committee:: GU
Sec. Committees:

Pharmas:: Genentech
Grants:: U10CA180821, U10CA180882, U24CA196171, UG1CA233253, UG1CA233196, UG1CA233270, UG1CA233290, UG1CA233320, UG1CA233327, UG1CA233341, (PGRN) GM61390, U01GM61393, (NINR) P30NR014129, U10CA180820 (ECOG-ACRIN)

Corr. Author:
Authors:: Jai N. Patel Chen Jiang Kouros Owzar Daniel L. Hertz Janey Wang Flora A. Mulkey William K. Kelly Susan Halabi Yoichi Furukawa Cameron Lassiter Susan G. Dorsey Paula N. Friedman Eric J. Small Michael A. Carducci Michael J. Kelley Yusuke Nakamura Michiaki Kubo Mark J. Ratain Michael J. Morris Howard L. McLeod

Networks:: CA824, LAPS-IL036, LAPS-IL057, LAPS-MD017, LAPS-MN026, LAPS-NC007, LAPS-NY016, NC002

Study: CALGB-90401
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: Genetic association study, Risk factors